Clinical Trial Update: A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects [Phase 1]

View source ↗

Summary

GlaxoSmithKline sponsored a Phase 1 study to characterize the physiology of weight loss and regain under dietary, behavioral, and pharmacological interventions …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: GlaxoSmithKline | Conditions: Obesity | Phase 1 | Status: COMPLETED